Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype by Hall, C, Law, JP, Reyat, JS, Cumberland, MJ, Hang, S, Vo, NTN, Raniga, K, Weston, CJ, O'Shea, C, Townend, JN, Gehmlich, K, Ferro, CJ, Denning, C, Pavlovic, D

A longitudinal study of mitral regurgitation detected after acute myocardial infarction by Sharma, H, Yuan, M, Shakeel, I, Hodson, J, Radhakrishnan, A, Brown, S, May, J, O'Connor, K, Zia, N, Doshi, SN, Hothi, SS, Townend, JN, Myerson, SG, Ludman, PF, Steeds, RP, Nadir, MA

Improving the diagnosis of heart failure in patients with atrial fibrillation by Bunting, KV, Gill, SK, Sitch, A, Mehta, S, O'Connor, K, Lip, GY, Kirchhof, P, Strauss, VY, Rahimi, K, Camm, AJ, Stanbury, M, Griffith, M, Townend, JN, Gkoutos, GV, Karwath, A, Steeds, RP, Kotecha, D

Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial by Kotecha, D, Bunting, KV, Gill, SK, Mehta, S, Stanbury, M, Jones, JC, Haynes, S, Calvert, MJ, Deeks, JJ, Steeds, RP, Strauss, VY, Rahimi, K, Camm, AJ, Griffith, M, Lip, GYH, Townend, JN, Kirchhof, P, Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) Team